Showing results (1-10 of 530) with videos related to
Sort By:
Pageof 53
Circulation. Heart Failure|December 22, 2012
Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacyMathew S Maurer, Sergio Teruya, Bibhas Chakraborty, et al.Congestive Heart Failure (Greenwich, Conn.)|June 19, 2010
The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fractionRose S Cohen, Paula Karlin, Madeline Yushak, et al.The American Journal of Cardiology|October 22, 2008
Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractionsDmitry Abramov, Rose S Cohen, Stuart D Katz, et al.Congestive Heart Failure (Greenwich, Conn.)|November 25, 2010
Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failureHannah Rosenblum, Stephen Helmke, Paula Williams, et al.The American Journal of Medicine|June 21, 2015
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear CardiologyMathew S MaurerThe American Journal of Cardiology|November 12, 2022
Overview of Current and Emerging Therapies for Amyloid Transthyretin CardiomyopathyMathew S MaurerThe American Journal of Cardiology|May 18, 2012
Cardiac transplantation in patients with hypertrophic cardiomyopathyTomoko S Kato, Hiroo Takayama, Saeko Yoshizawa, et al.Current Treatment Options in Cardiovascular Medicine|June 5, 2012
Heart failure with a normal ejection fraction: treatments for a complex syndrome?Samuel Bernard, Mathew S MaurerTherapeutic Advances in Cardiovascular Disease|April 2, 2026
ATTR-CM: What do we know about blood levels of the TTR protein? A discussion with expertsMathew S Maurer, Adam CastañoAnnual Review of Medicine|January 28, 2020
Cardiac Amyloidosis: Overlooked, Underappreciated, and TreatableJonah Rubin, Mathew S MaurerPageof 53